Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

TFF Pharmaceuticals And 3 Other Stocks Under $5 Insiders Are Aggressively Buying

Published 14/03/2023, 12:37
© Reuters.  TFF Pharmaceuticals And 3 Other Stocks Under $5 Insiders Are Aggressively Buying
BYFC
-
PGRE
-
CWQXY
-

Benzinga - The Dow Jones closed lower on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Paramount Group

  • The Trade: Paramount Group, Inc. (NYSE: PGRE) Director Thomas Armbrust acquired a total of 20,000 shares an average price of $4.85. To acquire these shares, it cost around $97 thousand.
  • What’s Happening: Paramount Group reported a rise in quarterly earnings.
  • What Paramount Group Does: Paramount Group Inc is a real estate investment trust engaged in owning, operating, managing, acquiring, and redeveloping high-quality, Class A office properties in select central business district ("CBD") submarkets of New York City and San Francisco.
Castellum
  • The Trade: Castellum, Inc. (NYSE: CTM) 10% owner Jay Wright acquired a total 10,600 shares at an average price of $1.04. The insider spent around $11.04 thousand to buy those shares.
  • What’s Happening: Castellum recently reported a $500,000 equity financing.
  • What Castellum Does: Castellum Inc, formerly BioNovelus Inc is engaged in acquiring and growing technology companies in the areas of information technology and cybersecurity with businesses in the public (government) and private (commercial) markets.
Check This Out: Lennar, Caleres And 3 Stocks To Watch Heading Into Tuesday

TFF Pharmaceuticals

  • The Trade: TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) President and CEO Harlan F Weisman acquired a total of 150,000 shares at an average price of $0.88. To acquire these shares, it cost around $131.84 thousand.
  • What’s Happening: TFF Pharmaceuticals posted a 2022 net loss of $31.8 million, versus a net loss of $31.0 million in 2021.
  • What TFF Pharmaceuticals Does: TFF Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform.
Don’t forget to check out our premarket coverage here

Broadway Financial

  • The Trade: Broadway Financial Corporation (NASDAQ: BYFC) Director William Longbrake acquired a total of 7,500 shares at an average price of $1.18. The insider spent $8.85 thousand to buy those shares.
  • What’s Happening: Broadway Financial posted a profir for the fourth quarter.
  • What Broadway Financial Does: Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.